Guobang Pharma (SH:605507) Zheng Quan Zhi Xing·2025-08-21 16:36Core Points - The report outlines a share acquisition by Zhejiang Provincial State-owned Capital Operation Co., Ltd. in Guobang Pharmaceutical Group Co., Ltd. [1][5] - The acquisition involves a total of 38,306,303 shares, representing 6.85% of the company's total share capital [6][10] - The share transfer price is set at 20.66 RMB per share, totaling approximately 791.41 million RMB [6][7] Section Summaries Section 1: Declaration - The report is prepared in accordance with relevant Chinese securities laws and regulations [1] - The information disclosing party has obtained necessary authorizations and approvals for the report [1] Section 2: Information Disclosing Party - The disclosing party is Zhejiang Provincial State-owned Capital Operation Co., Ltd., established on February 15, 2007, with a registered capital of 1 billion RMB [3][4] - The company is wholly owned by the Zhejiang Provincial Government [4] Section 3: Purpose of Equity Change and Shareholding Plan - The purpose of the equity change is driven by the disclosing party's investment needs and recognition of Guobang Pharmaceutical's development prospects [5] - There are no plans for further share increases or decreases within the next 12 months, aside from the current agreement [5] Section 4: Method of Equity Change - The equity change is executed through a share transfer agreement with three parties, resulting in the acquisition of 38,306,303 shares [6][9] - The disclosing party will become a shareholder holding more than 5% of the company post-transaction [6][10] Section 5: Recent Trading Activity - There have been no other transactions involving the buying or selling of shares in the past six months, aside from the disclosed equity change [10] Section 6: Other Significant Matters - The disclosing party confirms that all relevant information regarding the equity change has been disclosed accurately and completely [10]